Tests have detected PFAS in private wells and in drinking water sources that are tapped by hundreds of public utilities throughout the state.

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion. Under the terms of the deal, the company will gain the exclusive global ...

But a new report says it's important to consider what kind of bands we put on them, as several popular brands were found to contain high levels of a class of chemicals linked to health issues.

Merck on Wednesday said it has snagged the rights to an experimental weight loss pill from Chinese drugmaker Hansoh Pharma, in a deal worth up to $2 billion. Merck will pay Hansoh $112 million ...

Kirillov was the commander of Russia’s Radiation, Chemical and Biological Protection Forces, and is thought to be the most senior military figure assassinated in Russia since the country invaded ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a preclinical drug. The Big Pharma already has efinopegdutide, a dual GLP-1 ...

Dec 18 (Reuters) - Merck (MRK.N), opens new tab has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's (3692.HK), opens new tab experimental oral drug to treat ...

ROCKINGHAM COUNTY, Va. (WHSV) - Two people have been injured in an incident at Merck in Elkton. According to Rockingham County Fire & Rescue Chief Jeremy Holloway, one person was flown to RMH ...

Merck's strong financial performance in oncology and vaccines drove a 9% sales increase earlier in Q1 of 2024, despite challenges with other products. Promising future developments include ...

Merck, a leading science and technology company, has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that ...

Merck announced on Monday that it will discontinue the development of two cancer assets, vibostolimab and favezelimab, following underwhelming Phase III data. The pharma was studying both candidates ...

In 2020, the Covid-19 pandemic brought with it unstable market conditions for the chemicals industry, leading to weak demand, reduced production and lower revenues. Four years on, despite temporary ...